Published in Pediatrics on August 01, 1972
An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Lond) (1984) 3.38
Erythema infectiosum and pregnancy-related complications. CMAJ (1990) 1.40
Detection of antibodies to human parvovirus in erythema infectiosum (fifth disease). Arch Dis Child (1984) 1.02
Erythema infectiosum: an epidemic with a probable posterythema phase. Can Med Assoc J (1984) 0.79
Erythema infectiosum: an epidemic that mimics rubeola. Can Fam Physician (1982) 0.75
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med (1997) 17.51
Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer (1979) 5.60
Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science (1996) 4.72
Survival of influenza viruses on environmental surfaces. J Infect Dis (1982) 3.51
Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) (1980) 3.42
Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N Engl J Med (1993) 3.34
Assessment of signs of influenza illness in the ferret model. J Virol Methods (1989) 3.07
Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med (1989) 2.77
Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. Ann Intern Med (1990) 2.53
Failure of automatic control of ventilation (Ondine's curse). Report of an infant born with this syndrome and review of the literature. Medicine (Baltimore) (1970) 2.44
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44
Rapid and sensitive viral culture method for human immunodeficiency virus type 1. J Clin Microbiol (1988) 2.22
Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis (1989) 2.21
Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients. J Infect Dis (1997) 2.18
Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. J Clin Microbiol (1992) 1.99
Acyclovir therapy for acute herpes zoster. Lancet (1982) 1.95
Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med (1983) 1.90
Therapy of herpes zoster with oral acyclovir. Am J Med (1988) 1.89
Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals. J Clin Microbiol (1990) 1.88
Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet (1981) 1.86
Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers. Lancet (1977) 1.85
Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts. JAMA (1987) 1.84
Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications. Ann Intern Med (1989) 1.84
Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis (1998) 1.83
Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus. J Clin Microbiol (2007) 1.77
Transmission of hepatitis B virus in clinical laboratory areas. J Infect Dis (1979) 1.77
Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med (1988) 1.75
Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis (1986) 1.68
California arbovirus (La Crosse) infections. I. Clinical and laboratory findings in 66 children with meningoencephalitis. Pediatrics (1973) 1.62
Practical diagnostic testing for human immunodeficiency virus. Clin Microbiol Rev (1988) 1.61
Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS (1990) 1.61
Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. Rev Infect Dis (1991) 1.58
Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet (1981) 1.58
Recovery of human immunodeficiency virus from ocular tissues in patients with acquired immune deficiency syndrome. Ophthalmology (1988) 1.57
Human pharmacokinetics of the antiviral drug DHPG. Clin Pharmacol Ther (1986) 1.57
Hemophiliacs with HIV antibody are actively infected. JAMA (1988) 1.55
Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am J Ophthalmol (1987) 1.54
Encephalitis associated with erythema infectiosum. J Pediatr (1970) 1.51
Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers. Infect Immun (1974) 1.50
Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49
Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med (1992) 1.47
Acyclovir therapy in neonates. J Pediatr (1991) 1.45
Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45
The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group. JAMA (1994) 1.41
Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood (1986) 1.40
Transmission of rubella from newborns. A controlled study among young adult women and report of an unusual case. Am J Dis Child (1965) 1.39
Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine (Baltimore) (1986) 1.38
Rubella, measles and mumps antibodies following vaccination of children. A potential rubella problem. Am J Dis Child (1978) 1.37
Absence of HIV-1 infection in antibody-negative sexual partners of HIV-1 infected hemophiliacs. Transfusion (1989) 1.36
Rubella reimmunization now. Am J Dis Child (1979) 1.33
Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis (1990) 1.32
Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta. J Immunol (1991) 1.31
Sensitive microculture method for isolation of human immunodeficiency virus type 1 from blood leukocytes. J Clin Microbiol (1992) 1.29
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.28
Reye's syndrome: epidemiologic and viral studies, 1963-1974. Am J Epidemiol (1975) 1.28
Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results. Ophthalmology (1989) 1.25
Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis (1991) 1.23
Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J Med Virol (1993) 1.22
A seroepidemiologic study of a measles epidemic in a highly immunized population. Am J Epidemiol (1972) 1.21
Concentration-controlled zidovudine therapy. Clin Pharmacol Ther (1998) 1.20
Evidence for natural reassortants of human rotaviruses belonging to different genogroups. J Virol (1990) 1.20
Association of Reye's syndrome with viral infection. Lancet (1974) 1.17
Infectious diseases in hospitalized renal transplant recipients: a prospective study of a complex and evolving problem. Medicine (Baltimore) (1982) 1.16
Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J Neuroimmunol (1994) 1.16
Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med (1982) 1.16
Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS-related complex. JAMA (1988) 1.15
Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis. J Infect Dis (1998) 1.15
Measles control: so near and yet so far. Prog Med Virol (1985) 1.14
California arbovirus (La Crosse) infections. II. Precipitin antibody tests for the diagnosis of California encephalitis. Infect Immun (1973) 1.14
Cellular immune response to cytomegalovirus infection after renal transplantation. Infect Immun (1978) 1.13
Risk factors in the development of cytomegalovirus-related pneumonia in renal transplant recipients. J Infect Dis (1983) 1.13
Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. Vaccine (1998) 1.12
Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism. J Clin Invest (1992) 1.12
Treating mammalian bite wounds. J Clin Pharm Ther (2000) 1.12
Complement is activated in the upper respiratory tract during influenza virus infection. Am Rev Respir Dis (1991) 1.11
Acyclovir in immunocompromised patients with cytomegalovirus disease. A controlled trial at one institution. Am J Med (1982) 1.11
Rubella-vaccinated students. Follow-up in a public school system. JAMA (1978) 1.10
Proposed mechanisms and preventative options of Jarisch-Herxheimer reactions. J Clin Pharm Ther (2005) 1.10
Measles IgM response during reinfection of previously vaccinated children. J Pediatr (1973) 1.10
Cold agglutinins in infectious mononucleosis and heterophil-antibody-negative mononucleosis-like syndromes. Blood (1977) 1.10
Rubella vaccine evaluation in a public school system. Am J Dis Child (1969) 1.09
Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants. Surgery (1981) 1.08
Options for prevention of cytomegalovirus disease. Ann Intern Med (1991) 1.08
Comparison of reverse transcriptase assay with the Retro-Tek viral capture assay for detection of human immunodeficiency virus. Diagn Microbiol Infect Dis (1987) 1.06
Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection. Adv Exp Med Biol (1993) 1.06
Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope. Proc Natl Acad Sci U S A (1992) 1.05
Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis (1978) 1.05
Resistance of human immunodeficiency virus type 1 to antiretroviral agents: a review. Clin Infect Dis (1994) 1.04
Epstein-Barr virus antibody responses and clinical illness in renal transplant recipients. Surgery (1979) 1.04
Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. Antiviral Res (1989) 1.04
Fever in renal transplant recipients: causes, prognostic significance and changing patterns at the University of Minnesota Hospital. Am J Med (1981) 1.02
A trial of vidarabine for cytomegalovirus infection in renal transplant patients. Arch Intern Med (1980) 1.02
Local and systemic antibody response to rotavirus WC3 vaccine in adult volunteers. Antiviral Res (1989) 1.02